vs
Side-by-side financial comparison of Leslie's, Inc. (LESL) and NATURES SUNSHINE PRODUCTS INC (NATR). Click either name above to swap in a different company.
Leslie's, Inc. is the larger business by last-quarter revenue ($147.1M vs $123.8M, roughly 1.2× NATURES SUNSHINE PRODUCTS INC). NATURES SUNSHINE PRODUCTS INC runs the higher net margin — 3.3% vs -56.4%, a 59.7% gap on every dollar of revenue. On growth, NATURES SUNSHINE PRODUCTS INC posted the faster year-over-year revenue change (4.7% vs -16.0%). NATURES SUNSHINE PRODUCTS INC produced more free cash flow last quarter ($7.6M vs $-85.5M). Over the past eight quarters, NATURES SUNSHINE PRODUCTS INC's revenue compounded faster (5.6% CAGR vs -11.7%).
Leslie's, Inc., operating as Leslie's Swimming Pool Supplies, is the largest retailer of swimming pool supplies and related products. The company is headquartered in Phoenix, Arizona, and has a particularly strong retail presence in Arizona, California, Florida, Georgia and Texas.
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
LESL vs NATR — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $147.1M | $123.8M |
| Net Profit | $-83.0M | $4.1M |
| Gross Margin | 18.4% | 72.5% |
| Operating Margin | -46.7% | 4.3% |
| Net Margin | -56.4% | 3.3% |
| Revenue YoY | -16.0% | 4.7% |
| Net Profit YoY | -86.2% | 1379.4% |
| EPS (diluted) | $-8.92 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $147.1M | — | ||
| Q4 25 | $389.2M | $123.8M | ||
| Q3 25 | — | $128.3M | ||
| Q2 25 | $500.3M | $114.8M | ||
| Q1 25 | $177.1M | $113.2M | ||
| Q4 24 | $175.2M | $118.2M | ||
| Q3 24 | $397.9M | $114.6M | ||
| Q2 24 | $569.6M | $110.6M |
| Q1 26 | $-83.0M | — | ||
| Q4 25 | $-162.8M | $4.1M | ||
| Q3 25 | — | $5.3M | ||
| Q2 25 | $21.7M | $5.3M | ||
| Q1 25 | $-51.3M | $4.7M | ||
| Q4 24 | $-44.6M | $-321.0K | ||
| Q3 24 | $-9.9M | $4.3M | ||
| Q2 24 | $60.6M | $1.3M |
| Q1 26 | 18.4% | — | ||
| Q4 25 | 38.6% | 72.5% | ||
| Q3 25 | — | 73.3% | ||
| Q2 25 | 39.6% | 71.7% | ||
| Q1 25 | 24.8% | 72.1% | ||
| Q4 24 | 27.2% | 72.0% | ||
| Q3 24 | 36.0% | 71.3% | ||
| Q2 24 | 40.2% | 71.4% |
| Q1 26 | -46.7% | — | ||
| Q4 25 | -38.6% | 4.3% | ||
| Q3 25 | — | 7.0% | ||
| Q2 25 | 13.7% | 3.7% | ||
| Q1 25 | -27.3% | 5.4% | ||
| Q4 24 | -22.7% | 3.8% | ||
| Q3 24 | 6.6% | 4.6% | ||
| Q2 24 | 17.2% | 5.1% |
| Q1 26 | -56.4% | — | ||
| Q4 25 | -41.8% | 3.3% | ||
| Q3 25 | — | 4.2% | ||
| Q2 25 | 4.3% | 4.6% | ||
| Q1 25 | -29.0% | 4.2% | ||
| Q4 24 | -25.4% | -0.3% | ||
| Q3 24 | -2.5% | 3.8% | ||
| Q2 24 | 10.6% | 1.2% |
| Q1 26 | $-8.92 | — | ||
| Q4 25 | $-20.59 | $0.23 | ||
| Q3 25 | — | $0.30 | ||
| Q2 25 | $0.12 | $0.28 | ||
| Q1 25 | $-0.28 | $0.25 | ||
| Q4 24 | $-4.82 | $-0.02 | ||
| Q3 24 | $-2.46 | $0.23 | ||
| Q2 24 | $0.33 | $0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.6M | $93.9M |
| Total DebtLower is stronger | $781.6M | — |
| Stockholders' EquityBook value | $-489.9M | $161.6M |
| Total Assets | $649.4M | $261.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $3.6M | — | ||
| Q4 25 | $64.3M | $93.9M | ||
| Q3 25 | — | $95.6M | ||
| Q2 25 | $42.7M | $81.3M | ||
| Q1 25 | $17.3M | $86.5M | ||
| Q4 24 | $11.6M | $84.7M | ||
| Q3 24 | $108.5M | $78.7M | ||
| Q2 24 | $74.4M | $68.7M |
| Q1 26 | $781.6M | — | ||
| Q4 25 | $756.6M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $776.6M | — | ||
| Q1 25 | $858.1M | — | ||
| Q4 24 | $796.6M | — | ||
| Q3 24 | $783.7M | — | ||
| Q2 24 | $783.7M | — |
| Q1 26 | $-489.9M | — | ||
| Q4 25 | $-408.0M | $161.6M | ||
| Q3 25 | — | $166.7M | ||
| Q2 25 | $-246.2M | $163.7M | ||
| Q1 25 | $-269.5M | $167.1M | ||
| Q4 24 | $-220.0M | $161.0M | ||
| Q3 24 | $-177.1M | $162.6M | ||
| Q2 24 | $-168.2M | $156.4M |
| Q1 26 | $649.4M | — | ||
| Q4 25 | $741.5M | $261.1M | ||
| Q3 25 | — | $264.8M | ||
| Q2 25 | $989.5M | $254.9M | ||
| Q1 25 | $1.0B | $252.7M | ||
| Q4 24 | $967.0M | $240.9M | ||
| Q3 24 | $1.1B | $245.3M | ||
| Q2 24 | $1.1B | $235.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-81.1M | $9.9M |
| Free Cash FlowOCF − Capex | $-85.5M | $7.6M |
| FCF MarginFCF / Revenue | -58.1% | 6.1% |
| Capex IntensityCapex / Revenue | 2.9% | 1.9% |
| Cash ConversionOCF / Net Profit | — | 2.41× |
| TTM Free Cash FlowTrailing 4 quarters | $7.6M | $28.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $-81.1M | — | ||
| Q4 25 | $48.2M | $9.9M | ||
| Q3 25 | — | $18.5M | ||
| Q2 25 | $114.9M | $4.3M | ||
| Q1 25 | $-49.2M | $2.6M | ||
| Q4 24 | $-105.1M | $12.2M | ||
| Q3 24 | $47.1M | $9.6M | ||
| Q2 24 | $175.5M | $1.3M |
| Q1 26 | $-85.5M | — | ||
| Q4 25 | $41.8M | $7.6M | ||
| Q3 25 | — | $16.8M | ||
| Q2 25 | $107.1M | $3.0M | ||
| Q1 25 | $-55.8M | $1.5M | ||
| Q4 24 | $-109.8M | $10.0M | ||
| Q3 24 | $34.1M | $7.9M | ||
| Q2 24 | $165.2M | $-2.0M |
| Q1 26 | -58.1% | — | ||
| Q4 25 | 10.7% | 6.1% | ||
| Q3 25 | — | 13.1% | ||
| Q2 25 | 21.4% | 2.6% | ||
| Q1 25 | -31.5% | 1.3% | ||
| Q4 24 | -62.6% | 8.5% | ||
| Q3 24 | 8.6% | 6.9% | ||
| Q2 24 | 29.0% | -1.9% |
| Q1 26 | 2.9% | — | ||
| Q4 25 | 1.7% | 1.9% | ||
| Q3 25 | — | 1.3% | ||
| Q2 25 | 1.6% | 1.2% | ||
| Q1 25 | 3.7% | 1.0% | ||
| Q4 24 | 2.7% | 1.9% | ||
| Q3 24 | 3.2% | 1.5% | ||
| Q2 24 | 1.8% | 3.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.41× | ||
| Q3 25 | — | 3.46× | ||
| Q2 25 | 5.29× | 0.81× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.21× | ||
| Q2 24 | 2.89× | 0.97× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LESL
Segment breakdown not available.
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
